ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666302 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666302; 2) Community: the network communities that were significantly associated with the response to NSC 666302; 3) Molecule: the relationships between components within communities and NSC 666302; 4) MDR: the compounds that were significantly associated with the NSC 666302.

NSC Compound Enrichment Correlation
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0407060322613562 0.78577339
NSC 623436 TGF.alpha.-PE40 0.0407060322613562 -0.41616356
NSC 625496 Null 0.0407060322613562 0.4752695
NSC 630608 Null 0.0407060322613562 0.60891574
NSC 634035 4-amino-3-iodo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.0407060322613562 0.54803705
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.0407060322613562 0.56195752
NSC 637828 Spiro[5H-dibenzo[a,d]cycloheptene-5,2'(3'H)-furan]-5'-one, 4',5'-dihydro-4'-methylene- 0.0407060322613562 0.7499794
NSC 645317 Sanguilutine pseudobase 0.0407060322613562 0.43357664
NSC 656209 Null 0.0407060322613562 0.78760455
NSC 657270 (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.0407060322613562 0.30651354
Total:76  Current:70    [First] [Prev] [Next] [Last]